Diastolic dysfunction and cardiac troponin i decrease in aging hearts

Archives of Biochemistry and Biophysics

Volumn 603, Issue , 2016, Pages 20-28

  Pan, B ^a,b,c,d   Xu, Z W ^a,b,c,d   Xu, Y ^a,b,c,d   Liu, L J ^b,c,d   Zhu, J ^b,c,d   Wang, X ^e   Nan, C ^e   Zhang, Z ^e   Shen, W ^e   Huang, X P ^e   Tian, J ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c CHONGQING KEY LABORATORY OF PEDIATRICS   (China)

^d Science and Technology Information Center of Chongqing   (China)

^e FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Diastolic dysfunction; Epigenetics; Gene expression; Histone acetylation; Troponin

Indexed keywords

DNA; HISTONE; TROPONIN I;

ADULT; AGING; ANIMAL EXPERIMENT; ANIMAL IMAGING SYSTEM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC TROPONIN I GENE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DNA METHYLATION; ECHOCARDIOGRAPHY; EPIGENETICS; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; HEART; HEART FUNCTION; HISTONE ACETYLATION; IMAGING SOFTWARE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TISSUE LEVEL; YOUNG ADULT; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CARDIOMYOPATHY; CHROMATIN IMMUNOPRECIPITATION; DIASTOLE; GENETIC EPIGENESIS; METABOLISM; PHYSIOLOGY;

AGING; ANIMALS; CARDIOMYOPATHIES; CHROMATIN IMMUNOPRECIPITATION; DIASTOLE; ECHOCARDIOGRAPHY; EPIGENESIS, GENETIC; HEART; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; TROPONIN I;

EID: 84969611118     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2016.05.008     Document Type: Article

References (43)

1. L.S. Tobacman Thin filament-mediated regulation of cardiac contraction Annu. Rev. Physiol. 58 1996 447 481 10.1146/annurev.ph.58.030196.002311
2. X. Huang, and et al. Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency Cir. Res. 84 1999 1 8
3. X. Huang, and et al. Thyroid hormone regulates slow skeletal troponin I gene inactivation in cardiac troponin I null mouse hearts J. Mol. Cell. Cardiol. 32 2000 2221 2228 10.1006/jmcc.2000.1249
4. J. Du, C. Zhang, J. Liu, C. Sidky, and X.P. Huang A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice Arch. Biochem. Biophys. 456 2006 143 150 10.1016/j.abb.2006.08.018
5. J. Du, and et al. Functional characterization of mouse fetal TnI gene promoters in myocardial cells J. Biomed. Sci. 15 2008 605 613 10.1007/s11373-008-9246-y
6. J. Liu, J. Du, C. Zhang, J.W. Walker, and X. Huang Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice Am. J. Physiol. Heart Cir. Physiol. 293 2007 H1273 H1281 10.1152/ajpheart.01379.2006
7. Y. Li, and et al. Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy J. Mol. Cell. Cardiol. 49 2010 402 411 10.1016/j.yjmcc.2010.04.017
8. Y. Li, and et al. Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations J. Mol. Cell. Cardiol. 62 2013 227 236 10.1016/j.yjmcc.2013.06.007
9. L. Zhang, and et al. Calcium desensitizer catechin reverses diastolic dysfunction in mice with restrictive cardiomyopathy Arch. Biochem. Biophys. 573 2015 69 76 10.1016/j.abb.2015.03.015
10. L. Mandinov, F.R. Eberli, C. Seiler, and O.M. Hess Diastolic heart failure Cardiovasc. Res. 45 2000 813 825
11. M.L. Alves, and et al. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins Circ. Cardiovasc. Genet. 7 2014 132 143 10.1161/CIRCGENETICS.113.000324
12. T.M. Welsh, G.D. Kukes, and L.M. Sandweiss Differences of creatine kinase MB and cardiac troponin I concentrations in normal and diseased human myocardium Ann. Clin. Lab. Sci. 32 2002 32 49
13. P.K. Bhavsar, K.A. Dellow, M.H. Yacoub, N.J. Brand, and P.J. Barton Identification of cis-acting DNA elements required for expression of the human cardiac troponin I gene promoter J. Mol. Cell. Cardiol. 32 2000 95 108 10.1006/jmcc.1999.1058
14. R. Di Lisi, and et al. Combinatorial cis-acting elements control tissue-specific activation of the cardiac troponin I gene in vitro and in vivo J. Biol. Chem. 273 1998 25371 25380
15. R. Di Lisi, A. Picard, S. Ausoni, and S. Schiaffino GATA elements control repression of cardiac troponin I promoter activity in skeletal muscle cells BMC Mol. Biol. 8 2007 78 10.1186/1471-2199-8-78
16. S. Stefanovic, and et al. GATA-dependent regulatory switches establish atrioventricular canal specificity during heart development Nat. Commun. 5 2014 3680 10.1038/ncomms4680
17. C. Lopez-Otin, M.A. Blasco, L. Partridge, M. Serrano, and G. Kroemer The hallmarks of aging Cell 153 2013 1194 1217 10.1016/j.cell.2013.05.039
18. K. Gronbaek, C. Hother, and P.A. Jones Epigenetic changes in cancer APMIS Acta Pathologica, Microbiol. Immunol. Scand. 115 2007 1039 1059 10.1111/j.1600-0463.2007.apm-636.xml.x
19. J.L. Glass, and et al. CG dinucleotide clustering is a species-specific property of the genome Nucleic Acids Res. 35 2007 6798 6807 10.1093/nar/gkm489
20. J. Backs, and E.N. Olson Control of cardiac growth by histone acetylation/deacetylation Cir. Res. 98 2006 15 24 10.1161/01.RES.0000197782.21444.8f
21. T. Jenuwein, and C.D. Allis Translating the histone code Sci. (New York, N. Y.) 293 2001 1074 1080
22. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals eighth ed. 2011 National Academies Press (US) Washington (DC)
23. Kenneth J. Livaka, and Thomas D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method Methods Methods 25 2001 402 408
24. E. Braunwald The management of heart failure: the past, the present, and the future Circ. Heart Fail. 1 2008 58 62 10.1161/CIRCHEARTFAILURE.107.752162
25. J.S. Gottdiener, and et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study J. Am. Coll. Cardiol. 35 2000 1628 1637
26. R.S. Bhatia, and et al. Outcome of heart failure with preserved ejection fraction in a population-based study N. Engl. J. Med. 355 2006 260 269 10.1056/NEJMoa051530
27. L. Liao, and et al. Costs for heart failure with normal vs reduced ejection fraction Arch. Intern. Med. 166 2006 112 118 10.1001/archinte.166.1.112
28. T.E. Owan, and et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction N. Engl. J. Med. 355 2006 251 259 10.1056/NEJMoa052256
29. B.A. Steinberg, and et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes Circulation 126 2012 65 75 10.1161/CIRCULATIONAHA.111.080770
30. G.C. Fonarow, and et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure JAMA 297 2007 61 70 10.1001/jama.297.1.61
31. M.M. Redfield, and et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
32. G.C. Kane, and et al. Progression of left ventricular diastolic dysfunction and risk of heart failure JAMA 306 2011 856 863 10.1001/jama.2011.1201
33. V.L. Roger, and et al. Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350 10.1001/jama.292.3.344
34. S. Pikkarainen, H. Tokola, R. Kerkela, and H. Ruskoaho GATA transcription factors in the developing and adult heart Cardiovasc. Res. 63 2004 196 207 10.1016/j.cardiores.2004.03.025
35. I.R. Kuisk, H. Li, D. Tran, and Y. Capetanaki A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis Dev. Biol. 174 1996 1 13 10.1006/dbio.1996.0046
36. R.J. van Oort, and et al. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure Circulation 114 2006 298 308 10.1161/CIRCULATIONAHA.105.608968
37. A. He, and et al. Dynamic GATA4 enhancers shape the chromatin landscape central to heart development and disease Nat. Commun. 5 2014 4907 10.1038/ncomms5907
38. R.S. Ross, S. Navankasattusas, R.P. Harvey, and K.R. Chien An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac ventricular specificity and established an anterior-posterior gradient of expression Development 122 1996 1799 1809
39. B. Pan, and et al. Alcohol consumption during gestation causes histone3 lysine9 hyperacetylation and an alternation of expression of heart development-related genes in mice Alcohol. Clin. Exp. Res. 38 2014 2396 2402 10.1111/acer.12518
40. U. Schmidt, and et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase Circulation 101 2000 790 796
41. M. Weisfeldt Aging, changes in the cardiovascular system, and responses to stress Am. J. Hypertens. 11 1998 41S 45S
42. F.C. Yin, M.L. Weisfeldt, and W.R. Milnor Role of aortic input impedance in the decreased cardiovascular response to exercise with aging in dogs J. Clin. InvestigInvest.ation 68 1981 28 38
43. F.C. Yin, H.A. Spurgeon, K. Rakusan, M.L. Weisfeldt, and E.G. Lakatta Use of tibial length to quantify cardiac hypertrophy: application in the aging rat Am. J. Physiol. Genomics 243 1982 H941 H947